Dba Dynamic Sports Physical Therapy & Rehabilitation - Medicare Physical Therapist in Huntington, NY

Dba Dynamic Sports Physical Therapy & Rehabilitation is a medicare enrolled "Physical Therapist" provider in Huntington, New York. Their current practice location is 164 E Main St, Huntington, New York. You can reach out to their office (for appointments etc.) via phone at (631) 470-9515.

Dba Dynamic Sports Physical Therapy & Rehabilitation is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Dba Dynamic Sports Physical Therapy & Rehabilitation is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1780846154.

Contact Information

Dba Dynamic Sports Physical Therapy & Rehabilitation
164 E Main St,
Huntington, NY 11743-2955
(631) 470-9515
(631) 470-9513



Healthcare Provider's Profile

Full NameDba Dynamic Sports Physical Therapy & Rehabilitation
TypeFacility
SpecialityPhysical Therapist
Location164 E Main St, Huntington, New York
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1780846154
  • Provider Enumeration Date: 06/27/2008
  • Last Update Date: 08/12/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 7113083320
  • Enrollment ID: O20090312000387

Medical Identifiers

Medical identifiers for Dba Dynamic Sports Physical Therapy & Rehabilitation such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1780846154NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Dba Dynamic Sports Physical Therapy & Rehabilitation acts as a billing entity for following providers:
Provider NamePeter Yeager
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1598836710
PECOS PAC ID: 8527051002
Enrollment ID: I20040408000662

News Archive

Mylan introduces Methocarbamol Injection USP, 100 mg/mL in the U.S.

Mylan Inc. today announced the U.S. launch of its Methocarbamol Injection USP, 100 mg/mL, packaged in 1,000 mg/10 mL single-dose vials. This product is the generic version of Hikma Maple Ltd.'s Robaxin.

MMRF receives contract to analyze solid-organ transplantation data

As part of the federal government's ongoing effort to improve the lives of organ transplant recipients and patients awaiting organ transplants, the Health Resources and Services Administration (HRSA) has awarded researchers at the Minneapolis Medical Research Foundation (MMRF) a multimillion-dollar contract to maintain and analyze data on solid-organ transplantation in the United States.

Results from TITAN trial of CARILLON Mitral Contour System to be presented at ESC 2010 Congress

Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN trial of the Company's CARILLON Mitral Contour System will be presented at the European Society of Cardiology 2010 Congress on August 29, 2010 in Stockholm.

Cattle plague – rinderpest, eradicated for good

As welcome news, world farm monitors on Wednesday declared a cattle-killing virus that has been a curse through the ages as eradicated. This is the first time an animal disease has been eradicated in human history. The global watchdog for farm-animal trade approved a report certifying that the last 14 countries of the world were free of rinderpest, also called cattle plague.

Nuon Therapeutics advances NU1618 into phase 2b development for chronic hyperuricemia in gout patients

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.

Read more Medical News

› Verified 3 days ago

Provider NameElizabeth Perlstein
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1184798415
PECOS PAC ID: 2365406584
Enrollment ID: I20041117000903

News Archive

Mylan introduces Methocarbamol Injection USP, 100 mg/mL in the U.S.

Mylan Inc. today announced the U.S. launch of its Methocarbamol Injection USP, 100 mg/mL, packaged in 1,000 mg/10 mL single-dose vials. This product is the generic version of Hikma Maple Ltd.'s Robaxin.

MMRF receives contract to analyze solid-organ transplantation data

As part of the federal government's ongoing effort to improve the lives of organ transplant recipients and patients awaiting organ transplants, the Health Resources and Services Administration (HRSA) has awarded researchers at the Minneapolis Medical Research Foundation (MMRF) a multimillion-dollar contract to maintain and analyze data on solid-organ transplantation in the United States.

Results from TITAN trial of CARILLON Mitral Contour System to be presented at ESC 2010 Congress

Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN trial of the Company's CARILLON Mitral Contour System will be presented at the European Society of Cardiology 2010 Congress on August 29, 2010 in Stockholm.

Cattle plague – rinderpest, eradicated for good

As welcome news, world farm monitors on Wednesday declared a cattle-killing virus that has been a curse through the ages as eradicated. This is the first time an animal disease has been eradicated in human history. The global watchdog for farm-animal trade approved a report certifying that the last 14 countries of the world were free of rinderpest, also called cattle plague.

Nuon Therapeutics advances NU1618 into phase 2b development for chronic hyperuricemia in gout patients

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.

Read more Medical News

› Verified 3 days ago

Provider NameDana S Jahn
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1386692887
PECOS PAC ID: 7810150562
Enrollment ID: I20120517000119

News Archive

Mylan introduces Methocarbamol Injection USP, 100 mg/mL in the U.S.

Mylan Inc. today announced the U.S. launch of its Methocarbamol Injection USP, 100 mg/mL, packaged in 1,000 mg/10 mL single-dose vials. This product is the generic version of Hikma Maple Ltd.'s Robaxin.

MMRF receives contract to analyze solid-organ transplantation data

As part of the federal government's ongoing effort to improve the lives of organ transplant recipients and patients awaiting organ transplants, the Health Resources and Services Administration (HRSA) has awarded researchers at the Minneapolis Medical Research Foundation (MMRF) a multimillion-dollar contract to maintain and analyze data on solid-organ transplantation in the United States.

Results from TITAN trial of CARILLON Mitral Contour System to be presented at ESC 2010 Congress

Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN trial of the Company's CARILLON Mitral Contour System will be presented at the European Society of Cardiology 2010 Congress on August 29, 2010 in Stockholm.

Cattle plague – rinderpest, eradicated for good

As welcome news, world farm monitors on Wednesday declared a cattle-killing virus that has been a curse through the ages as eradicated. This is the first time an animal disease has been eradicated in human history. The global watchdog for farm-animal trade approved a report certifying that the last 14 countries of the world were free of rinderpest, also called cattle plague.

Nuon Therapeutics advances NU1618 into phase 2b development for chronic hyperuricemia in gout patients

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dba Dynamic Sports Physical Therapy & Rehabilitation is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dba Dynamic Sports Physical Therapy & Rehabilitation
164 E Main St,
Huntington, NY 11743-2955

Ph: (631) 470-9515
Dba Dynamic Sports Physical Therapy & Rehabilitation
164 E Main St,
Huntington, NY 11743-2955

Ph: (631) 470-9515

News Archive

Mylan introduces Methocarbamol Injection USP, 100 mg/mL in the U.S.

Mylan Inc. today announced the U.S. launch of its Methocarbamol Injection USP, 100 mg/mL, packaged in 1,000 mg/10 mL single-dose vials. This product is the generic version of Hikma Maple Ltd.'s Robaxin.

MMRF receives contract to analyze solid-organ transplantation data

As part of the federal government's ongoing effort to improve the lives of organ transplant recipients and patients awaiting organ transplants, the Health Resources and Services Administration (HRSA) has awarded researchers at the Minneapolis Medical Research Foundation (MMRF) a multimillion-dollar contract to maintain and analyze data on solid-organ transplantation in the United States.

Results from TITAN trial of CARILLON Mitral Contour System to be presented at ESC 2010 Congress

Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN trial of the Company's CARILLON Mitral Contour System will be presented at the European Society of Cardiology 2010 Congress on August 29, 2010 in Stockholm.

Cattle plague – rinderpest, eradicated for good

As welcome news, world farm monitors on Wednesday declared a cattle-killing virus that has been a curse through the ages as eradicated. This is the first time an animal disease has been eradicated in human history. The global watchdog for farm-animal trade approved a report certifying that the last 14 countries of the world were free of rinderpest, also called cattle plague.

Nuon Therapeutics advances NU1618 into phase 2b development for chronic hyperuricemia in gout patients

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.

Read more News

› Verified 3 days ago


Physical Therapist in Huntington, NY

John W Titcomb, P.T.
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 1206 E Jericho Tpke Unit A, Huntington, NY 11743
Phone: 631-549-0749    Fax: 631-549-1562
Mr. Ward Tucker Iii,
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 141 E Main St, Huntington, NY 11743
Phone: 631-421-9111    
Melanie Carminati,
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 13 South Ln, Huntington, NY 11743
Phone: 631-219-9194    
Steven Browning,
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 221 E Main St, Huntington, NY 11743
Phone: 631-533-2888    Fax: 631-638-5584
Zinnia Dodson,
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 221 E Main St, Huntington, NY 11743
Phone: 631-533-2888    
Mrs. Stephanie Foley, MS PT
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 467 New York Ave, Huntington, NY 11743
Phone: 631-424-1100    Fax: 631-424-1105
Norbert Jack Ryglewicz, MSPT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 232 E Main St, Huntington, NY 11743
Phone: 516-639-1819    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.